SYNGENE's Q2 FY27 numbers came in soft, with revenue of Rs. 832.70 Cr (-8.55% YoY) and PAT growth of -52.01% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 27, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 832.70 Cr (-8.55% YoY) |
| PAT (Q2) | Rs. 32.20 Cr (-52.01% YoY) |
| EBITDA margin | 17.70% (-421 bps YoY) |
| EPS (Q2) | Rs. 0.80 (-52.10% YoY) |
| Market cap | Rs. 14,786.47 Cr |
| CMP | Rs. 366.20 |
Q2 FY27 marked a sequential trough with revenue up 13.14% QoQ and operating EBITDA margin up 536 bps QoQ to 17.70%, but every YoY line remains down — revenue -8.55%, PAT -52.01%, margin -421 bps. The FY single-digit revenue-decline guidance is on track, but the mid-20s margin target requires H2 margins above the top of management's own 27-30% band. FX losses of Rs.61.4 Cr, a 31.5% ETR, negative H1 cash flow, and recurring termination-benefit charges weigh on the near-term earnings picture.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.